The primary prevention effect of losartan potassium on patients with hypertension and stroke
10.3760/cma.j.issn.1008-6706.2012.01.007
- VernacularTitle:氯沙坦对高血压伴心房纤颤患者脑卒中一级预防的效果研究
- Author:
Shunkai ZHANG
;
Lifen CHI
;
Xingyang YI
;
Xiangyang YE
;
Xixin WU
- Publication Type:Journal Article
- Keywords:
Hypertension;
Atrial fibrillation;
Losartan;
Stroke
- From:
Chinese Journal of Primary Medicine and Pharmacy
2012;19(1):13-14
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo study the effect of angiotensin Ⅱ type 1 receptor antagonist (ARB) losartan on reducing the incidence of stroke in patients which suffer from hypertension and atrial fibrillation(AF).MethodsProspective randomized analysis was used to divide one hundred and eighty hypertemion patients with atrial fibrillation into two groups.ARB treatment group was treated with losartan (n =90) and beta-blockers treatment group was treated with metoprolol ( n =90),all patients were treated for three years and followed up.Blood pressure,pulse pressure,incidence of stroke and myocardial infarction and mortality of cardiovascular events were evaluated.ResultsAfter antihypertensive treatment,blood pressure was reduced in two groups,the pulse pressure in losartan group was reduced obviously( all P ＜0.01 ).The incidence of stroke and myocardial infarction and mortality of cardiovascular events in losartan group were 22.2％,10.0％ and 13.3％,respectively,lower than that in metoprolol group 70.0％,40.0％ and 44.4％ ( all P ＜0.01 ).ConclusionLosartan reduced the incidence of stroke in the hypertension patients with AF.
